William Lis
Chief Executive Officer
material science
Portola Pharmaceuticals Inc
United States of America
Biography
William Lis joined Portola in 2008 as chief business officer and chief operating officer and was appointed chief executive officer in May 2010, with over 25 years of biopharmaceutical experience. Under his leadership, Portola has advanced several novel compounds into clinical development, successfully raised over $1.2 billion in private and public financings, including an initial public offering in 2013, and executed multiple partnerships for its programs.
Research Interest
material science
